Answers are grounded in this paper and cite their sources.
PI-RADS category 3 lesions represent uncertainty and equivocal findings, and incorporating prostate-specific antigen density into a risk-based diagnostic pathway may optimize the balance between avoiding unnecessary prostate biopsies and reducing the number of missed clinically significant prostate cancers.
No takes yet. Share an insight, caveat, or question.
Nicola et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: